In Europe, Centralized OTC Switch Still Has A Few Bugs
This article was originally published in The Tan Sheet
Executive Summary
The European Union's diversity means that when it comes to the new centralized procedure for Rx-to-OTC switches, there are several details yet to be ironed out, according to OTC industry executivesYou may also be interested in...
Novartis To Launch Nycomed's PPI Pantoloc Control In 14 European Countries
Novartis To Launch Nycomed's PPI Pantoloc Control In 14 European Countries
Novartis To Launch Nycomed's PPI Pantoloc Control In 14 European Countries
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: